EP3328437A4 - Composition pharmaceutique à stabilité au stockage améliorée, et son procédé de préparation - Google Patents

Composition pharmaceutique à stabilité au stockage améliorée, et son procédé de préparation Download PDF

Info

Publication number
EP3328437A4
EP3328437A4 EP16830853.4A EP16830853A EP3328437A4 EP 3328437 A4 EP3328437 A4 EP 3328437A4 EP 16830853 A EP16830853 A EP 16830853A EP 3328437 A4 EP3328437 A4 EP 3328437A4
Authority
EP
European Patent Office
Prior art keywords
preparing
pharmaceutical composition
same
storage stability
improved storage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16830853.4A
Other languages
German (de)
English (en)
Other versions
EP3328437A1 (fr
Inventor
Bong Oh Kim
Kyu Jin Kyung
Ji Yeong Kim
Hye Rim Kim
Bum Chan MIN
Yoo Jeong YOON
Min Hyo Seo
Yil Woong Yi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Samyang Biopharmaceuticals Corp
Original Assignee
Samyang Biopharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Biopharmaceuticals Corp filed Critical Samyang Biopharmaceuticals Corp
Publication of EP3328437A1 publication Critical patent/EP3328437A1/fr
Publication of EP3328437A4 publication Critical patent/EP3328437A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP16830853.4A 2015-07-28 2016-07-28 Composition pharmaceutique à stabilité au stockage améliorée, et son procédé de préparation Withdrawn EP3328437A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150106629 2015-07-28
PCT/KR2016/008270 WO2017018820A1 (fr) 2015-07-28 2016-07-28 Composition pharmaceutique à stabilité au stockage améliorée, et son procédé de préparation

Publications (2)

Publication Number Publication Date
EP3328437A1 EP3328437A1 (fr) 2018-06-06
EP3328437A4 true EP3328437A4 (fr) 2019-03-20

Family

ID=57884713

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16830853.4A Withdrawn EP3328437A4 (fr) 2015-07-28 2016-07-28 Composition pharmaceutique à stabilité au stockage améliorée, et son procédé de préparation

Country Status (13)

Country Link
EP (1) EP3328437A4 (fr)
JP (1) JP2018521105A (fr)
KR (1) KR101787453B1 (fr)
CN (1) CN107466231A (fr)
AU (1) AU2016299548A1 (fr)
BR (1) BR112018001737A2 (fr)
CA (1) CA2993928A1 (fr)
HK (1) HK1249441A1 (fr)
IL (1) IL257187A (fr)
MX (1) MX2018001223A (fr)
RU (1) RU2018107055A (fr)
WO (1) WO2017018820A1 (fr)
ZA (1) ZA201801187B (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001085216A1 (fr) * 2000-05-12 2001-11-15 Samyang Corporation Procede de preparation de micelle polymere via une separation de phases d'un copolymere sequence
WO2001087345A1 (fr) * 2000-05-17 2001-11-22 Samyang Corporation Composition medicamentseuse du type micelle polymere stable et son procede de preparation
US20100280214A1 (en) * 2007-12-31 2010-11-04 Samyang Corporation Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof
US20130345297A1 (en) * 2007-12-31 2013-12-26 Samyang Biopharmaceuticals Corporation Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020507A (en) 1998-03-02 2000-02-01 Bristol-Myers Squibb Company Synthesis of paclitaxel from baccatin III by protection of the 7-hydroxyl of baccatin III using a strong base and an electrophile
US7879317B2 (en) * 2001-10-18 2011-02-01 Samyang Corporation Polymeric micelle compositions with improved stability and methods of making thereof
WO2005037840A1 (fr) 2003-10-16 2005-04-28 Mayne Pharma (Usa), Inc. Methode pour inverser le groupe hydroxyle c2' d'esters de taxane
KR101024742B1 (ko) * 2007-12-31 2011-03-24 주식회사 삼양사 탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법
EP2201935B1 (fr) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Composition de micelles polymères contenant un médicament faiblement soluble et son procédé de préparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001085216A1 (fr) * 2000-05-12 2001-11-15 Samyang Corporation Procede de preparation de micelle polymere via une separation de phases d'un copolymere sequence
WO2001087345A1 (fr) * 2000-05-17 2001-11-22 Samyang Corporation Composition medicamentseuse du type micelle polymere stable et son procede de preparation
US20100280214A1 (en) * 2007-12-31 2010-11-04 Samyang Corporation Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof
US20130345297A1 (en) * 2007-12-31 2013-12-26 Samyang Biopharmaceuticals Corporation Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KIM S C ET AL: "In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 72, no. 1-3, 14 May 2001 (2001-05-14), pages 191 - 202, XP027296131, ISSN: 0168-3659, [retrieved on 20010514] *
See also references of WO2017018820A1 *
ZHU K J ET AL: "PREPARATION, CHARACTERIZATION, AND PROPERTIES OF POLYLACTIDE (PLA)-POLY(ETHYLENE GLYCOL) (PEG) COLOYMERS: A POTENTIAL DRUG CARRIER", JOURNAL OF APPLIED POLYMER SCIENCE, JOHN WILEY & SONS, INC, US, vol. 39, no. 1, 1 January 1990 (1990-01-01), pages 1 - 09, XP000650366, ISSN: 0021-8995, DOI: 10.1002/APP.1990.070390101 *

Also Published As

Publication number Publication date
HK1249441A1 (zh) 2018-11-02
AU2016299548A1 (en) 2018-02-22
CA2993928A1 (fr) 2017-02-02
RU2018107055A (ru) 2019-08-28
EP3328437A1 (fr) 2018-06-06
RU2018107055A3 (fr) 2019-08-28
WO2017018820A1 (fr) 2017-02-02
KR20170015200A (ko) 2017-02-08
MX2018001223A (es) 2018-11-09
KR101787453B1 (ko) 2017-10-19
JP2018521105A (ja) 2018-08-02
CN107466231A (zh) 2017-12-12
BR112018001737A2 (pt) 2018-09-11
IL257187A (en) 2018-03-29
ZA201801187B (en) 2018-12-19

Similar Documents

Publication Publication Date Title
EP3364951A4 (fr) Composition de nicotine pour dispositifs de vapotage et dispositifs de vapotage utilisant celle-ci
EP3197867A4 (fr) Nouveaux dérivés de 4-méthoxy pyrrole ou leurs sels, et composition pharmaceutique les comprenant
IL255691B (en) Methods for storage of whole blood, and corresponding preparations
EP3328562A4 (fr) Système et procédé de nettoyage sur place et composition associée
EP3319710A4 (fr) Composition et système de stockage de gaz
EP3130355A4 (fr) Composition pharmaceutique comprenant de la prégabaline, ayant une stabilité améliorée, et son procédé de préparation
EP3331947A4 (fr) Support de biomolécules à base de silice, composition pharmaceutique le comprenant, procédé de préparation et utilisation correspondants
EP3330379A4 (fr) Aptamère spécifique du récepteur d'insuline et composition pharmaceutique le contenant
HRP20200104T8 (hr) Novi heterociklični spoj, metoda za pripremu istog, i farmaceutska kompozicija koja sadrži isto
EP3207149A4 (fr) Composition pharmaceutique présentant une stabilité améliorée
EP3185873A4 (fr) Composition pharmaceutique et procédés
EP3328368A4 (fr) Composés et composition pharmaceutique associée au système d'ubiquitination-protéasome
EP3175845A4 (fr) Composition pharmaceutique comprenant une fonction de prévention d'abus
EP3384933A4 (fr) Composition d'alcool de sucre anhydre ayant une stabilité au stockage accrue et procédé de stockage d'alcool de sucre anhydre
HK1249442A1 (zh) 具有改善的儲存穩定性的藥物組合物及其製備方法
HK1249439A1 (zh) 具有改善的儲存穩定性的藥物組合物及其製備方法
EP3305283A4 (fr) Composition pharmaceutique stabilisée et son procédé de préparation
EP3349748A4 (fr) Composition et méthodes correspondantes
HK1249440A1 (zh) 具有改善的儲存穩定性的藥物組合物及其製備方法
EP3230940A4 (fr) Procédé de création d'un catalogue numérique interactif, et support de stockage lisible par ordinateur, et catalogue numérique interactif l'utilisant
EP3143017A4 (fr) Dérivés bicycliques et composition pharmaceutique les contenant
EP3175851A4 (fr) Utilisation de buténylphtalide, procédé pour son utilisation, et procédé pour le préparer en une composition pharmaceutqiue
HK1249441A1 (zh) 具有改善的儲存穩定性的藥物組合物及其製備方法
EP3310761A4 (fr) Procédés de stockage de plaquettes et compositions associées
EP3251672A4 (fr) Composition pharmaceutique et procédé de préparation de cette dernière

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20180228

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1249441

Country of ref document: HK

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20190215

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/107 20060101ALI20190211BHEP

Ipc: A61K 31/122 20060101ALI20190211BHEP

Ipc: A61K 47/34 20170101AFI20190211BHEP

Ipc: A61K 9/19 20060101ALI20190211BHEP

Ipc: A61K 31/337 20060101ALI20190211BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190917